Liver grafts from deceased donors with active SARS-CoV-2 infection carry an unknown risk of transmission. Recently, the OPTN Ad Hoc DTAC summary stated that the decision to recover organs from donors with active COVID-19 should consider the recipient's risk of mortality by delaying the transplantation while waiting for a suitable donor and the potential risk of donor-derived SARS-CoV-2 (1). With the high likelihood of persistent community transmission, many deceased donor livers from SARS-CoV-2 infected donors will not be transplanted (2).